AT292641T
Mucin-Mannan conjugates and their use in immunotherapy
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
48 members in 10 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| PM322393 | Australia | A |
Members48
| Document | Office | Kind | |
|---|---|---|---|
| CA2135833A1 | Canada | A1 | |
| EP0659768A2 | European Patent Office (EPO) | A2 | |
| AU8172894A | Australia | A | |
| WO9518145A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1308195A | Australia | A | |
| JPH07206707A | Japan | A | |
| EP0659768A3 | European Patent Office (EPO) | A3 | |
| AU685539B2 | Australia | B2 | |
| CA2304952A1 | Canada | A1 | |
| WO9916455A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU9455598A | Australia | A | |
| US5989552A | United States of America | A | |
| EP1027063A1 | European Patent Office (EPO) | A1 | |
| US6177256B1 | United States of America | B1 | |
| CA2399026A1 | Canada | A1 | |
| WO0157068A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2987701A | Australia | A | |
| JP2001517709A | Japan | A | |
| AU754065B2 | Australia | B2 | |
| EP1257565A1 | European Patent Office (EPO) | A1 | |
| US6548643B1 | United States of America | B1 | |
| JP2003533181A | Japan | A | |
| EP1027063A4 | European Patent Office (EPO) | A4 | |
| AU780395B2 | Australia | B2 | |
| EP0659768B1 | European Patent Office (EPO) | B1 | |
| EP1257565A4 | European Patent Office (EPO) | A4 | |
| AT292641TThis record | Austria | T | |
| ATE292641T1 | Austria | T1 | |
| DE69434324D1 | Germany | D1 | |
| DE69434324T2 | Germany | T2 | |
| JP3884088B2 | Japan | B2 | |
| US2007071765A1 | United States of America | A1 | |
| US2007092531A1 | United States of America | A1 | |
| JP2007197419A | Japan | A | |
| CA2135833C | Canada | C | |
| EP1027063B1 | European Patent Office (EPO) | B1 | |
| AT422893T | Austria | T | |
| ATE422893T1 | Austria | T1 | |
| DE69840578D1 | Germany | D1 | |
| DK1027063T3 | Denmark | T3 | |
| ES2322212T3 | Spain | T3 | |
| JP2011046723A | Japan | A | |
| JP4669930B2 | Japan | B2 | |
| JP4701146B2 | Japan | B2 | |
| US8021667B2 | United States of America | B2 | |
| CA2304952C | Canada | C | |
| JP5192020B2 | Japan | B2 | |
| US8771701B2 | United States of America | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 94303817
Titles2
- German
- MUCIN-MANNAN-KONJUGATE UND IHRE IMMUNOTHERAPEUTISCHE ANWENDUNG
- English
- MUCIN MANNAN CONJUGATES AND ITS IMMUNOTHERAPEUTIC APPLICATION
Classification
- CPC, 14
- C07K14/4727
- A61K2039/6087
- A61P31/04
- A61P31/06
- A61P31/12
- A61P31/14
- A61P31/16
- A61P31/18
- A61P33/06
- A61P35/00
- A61P37/04
- A61K39/00117
- C07K2319/00
- Y02A50/30
- IPC, 4
- A61K39 00
- A61K39 385
- A61P37 04
- C07K14 47